tiprankstipranks
Celldex Therapeutics Inc (CLDX)
NASDAQ:CLDX
Holding CLDX?
Track your performance easily

Celldex (CLDX) Financial Statements

1,067 Followers

Celldex Financial Overview

Celldex's market cap is currently ―. The company's EPS TTM is $-2.567; its P/E ratio is -9.79; Celldex is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $-0.73. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 3.19M$ 2.50M$ 156.00K$ 4.13M$ 1.52M
Gross Profit$ 3.19M$ 2.50M$ 156.00K$ 4.13M$ 1.52M
EBIT$ -42.12M$ -35.84M$ -40.61M$ -35.13M$ -41.24M
EBITDA$ -41.34M$ -31.73M$ -39.83M$ -34.37M$ -40.47M
Net Income Common Stockholders$ -42.12M$ -35.84M$ -32.81M$ -43.31M$ -38.26M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 756.00M$ 802.32M$ 823.85M$ 423.60M$ 235.35M
Total Assets$ 823.18M$ 845.59M$ 868.85M$ 465.63M$ 280.26M
Total Debt$ 3.09M$ 2.38M$ 2.11M$ 2.54M$ 2.85M
Net Debt$ -752.91M$ -799.93M$ -821.73M$ -421.06M$ -232.50M
Total Liabilities$ 37.27M$ 31.93M$ 30.23M$ 36.46M$ 33.54M
Stockholders Equity$ 785.90M$ 813.66M$ 838.61M$ 429.17M$ 246.72M
Cash Flow-
Free Cash Flow$ -55.84M$ -29.67M$ -40.94M$ -33.20M$ -19.15M
Operating Cash Flow$ -55.30M$ -29.40M$ -40.60M$ -32.53M$ -18.99M
Investing Cash Flow$ 47.76M$ -46.72M$ -315.21M$ -171.16M$ 11.65M
Financing Cash Flow$ 1.24M$ 3.71M$ 436.11M$ 217.37M$ 257.00K
Currency in USD

Celldex Earnings and Revenue History

Celldex Debt to Assets

Celldex Cash Flow

Celldex Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis